Pocket Program - CROI

CROI 2013 Session 52
e Wednesday, 4-6 pm; Ballroom 3-4
Session 51—Symposium
HIV Testing and Monitoring the Epidemic: New
Tools for Patients and Populations
Conveners:
Tsehaynesh Messele, African Society
for Lab Med, Addis Ababa, Ethiopia
Trevor Peter, Clinton Hlth Access
Initiative, Boston, MA, US
162
HIV Self-testing: Opportunities and
Challenges
Julie Myers
New York City Dept of Hlth and Mental Hygiene and Columbia
Univ Med Ctr, NY, US
163
When Diagnosis Gets up Close and Personal:
Point-of-Care Assays for Immunological and
Virological Monitoring of HIV Disease
Ilesh Jani
Inst Nacional de Saude, Maputo, Mozambique
164
Accurate Cross-sectional HIV Incidence Testing
Oliver Laeyendecker* 1,2 , R Brookmeyer 3 , M Kulich 4 ,
T Quinn 1,2 , J Konikoff 3 , M Cousins 2 , D Donnell 5,6 , and S Eshleman 2
1 NIAID, NIH, Baltimore MD, US;; 2 Johns Hopkins Univ,
Baltimore, MD, US;; 3 Univ of California, Los Angeles, US;;
4 Charles Univ Prague, Czech Republic;; 5 Fred Hutchinson
Cancer Res Ctr, Seattle, WA, US;; and 6 Univ of Washington,
Seattle, US
165
Viral Load Measures: Patients, Populations,
and Interpretations
Irene Hall
CDC, Atlanta, GA, US
Objectives: The session is directed to clinicians and
scientists interested in new laboratory methods for diagnosing HIV
infection and monitoring the impact of treatment on individuals and
populations. It is assumed that participants are familiar with the basic
methods used to diagnose HIV infection and monitor the response
to treatment. At the completion of the session, participants will be
knowledgeable about home testing for HIV, monitoring response
to therapy in resource-limited settings, measuring HIV incidence in
populations, and the effect of treatment on community viral load.
e Wednesday, 4-6 pm; Ballroom 1-2
Session 52—Symposium
TB on the Verge
Conveners:
Constance Benson, Univ of California,
San Diego Antiviral Res Ctr, US
Papa Salif Sow, Global Hlth Prgm, Bill &
Melinda Gates Fndn, Seattle, WA, US
166
Strategies for Prevention of Active TB
Gavin Churchyard
Aurum Inst and Sch of Publ Hlth, Univ of the Witwatersrand,
Johannesburg, South Africa
167
Impact of Rapid Diagnostic Testing—
Changing the TB Diagnostic Landscape
Catharina Boehme
Fndn for Innovative New Diagnostics, Geneva, Switzerland
168
Treatment of TB in Women and Children
Soumya Swaminathan
Natl Inst for Res in TB, Chennai, India
169
Management of Drug-resistant TB
Alexander Pym
KwaZulu-Natal Res Inst for TB and HIV, Nelson R Mandela Sch
of Med, Univ of KwaZulu-Natal, Durban, South Africa
Objectives: This session is directed to clinicians and scientists
interested in the pathogenesis, diagnosis, treatment, and prevention
of TB. It is assumed that participants are familiar with basic aspects
of the disease and the current tools available for management of
the disease. At the completion of the session, participants will be
knowledgeable about challenges and limitations in prevention of
HIV-related TB, newer molecular diagnostic tools for detecting
Mycobacterium tuberculosis and drug resistance, unique challenges
in the diagnosis and treatment of TB in pregnant women and children,
and new approaches for the treatment of multidrug resistant TB.
Program 23
Wednesday
March 6 Oral Sessions